Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,89.12,01/26/2015,GNRL,255691986
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,74.95,06/16/2014,GNRL,156575496
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,30.87,05/12/2014,GNRL,150865962
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,22.19,06/22/2015,GNRL,294851131
523205,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,21.21,12/30/2015,GNRL,290485690
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,20.94,12/08/2014,GNRL,165774386
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.12,05/12/2015,GNRL,256187067
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.37,10/24/2014,GNRL,148427494
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,18.20,12/14/2015,GNRL,295078310
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.58,06/18/2015,GNRL,256299492
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,17.34,10/05/2015,GNRL,294937416
523205,GNRL,"Sanofi Pasteur Inc.",PA,100000000299,16.16,10/15/2014,GNRL,182402918
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.08,08/17/2015,GNRL,295240482
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.78,09/03/2014,GNRL,148460470
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,15.65,04/06/2015,GNRL,294733208
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,15.61,02/18/2015,GNRL,294730366
523205,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.08,11/23/2015,GNRL,290485692
523205,GNRL,"LILLY USA, LLC",IN,100000000066,14.86,11/14/2014,GNRL,137911864
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.76,07/31/2015,GNRL,319493215
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.76,09/25/2015,GNRL,319703461
523205,GNRL,"Lilly USA, LLC",IN,100000000066,14.63,09/14/2015,GNRL,268031256
523205,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.61,01/21/2015,GNRL,290485696
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.57,01/07/2015,GNRL,265968188
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.37,08/12/2015,GNRL,319205608
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.28,02/04/2015,GNRL,255509091
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.28,02/09/2015,GNRL,275527050
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.27,03/27/2015,GNRL,319713800
523205,GNRL,"Lilly USA, LLC",IN,100000000066,14.14,07/20/2015,GNRL,268031254
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.09,06/26/2014,GNRL,149111062
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.09,11/26/2014,GNRL,156575494
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.03,01/09/2015,GNRL,255124110
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.01,11/07/2014,GNRL,162257912
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.00,05/20/2015,GNRL,256252900
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.95,07/02/2014,GNRL,161813594
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.77,12/05/2014,GNRL,150746488
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.69,04/17/2015,GNRL,275527064
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.56,06/24/2015,GNRL,275527068
523205,GNRL,"Supernus Pharmaceuticals, Inc.",MD,100000011150,13.56,12/02/2015,GNRL,335834750
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.48,12/11/2015,GNRL,267129306
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.44,11/18/2015,GNRL,275527056
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.43,08/20/2014,GNRL,149206783
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.42,06/08/2015,GNRL,266770766
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.38,04/22/2015,GNRL,275527054
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.32,05/05/2014,GNRL,150624740
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.32,12/06/2014,GNRL,150361360
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.31,09/29/2014,GNRL,156575512
523205,GNRL,"Actavis Pharma Inc",NJ,100000010642,13.25,07/10/2015,GNRL,339394278
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.18,07/25/2014,GNRL,150185393
523205,GNRL,"Supernus Pharmaceuticals, Inc.",MD,100000011150,13.09,09/02/2015,GNRL,335834748
523205,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,13.08,10/14/2015,GNRL,325048066
523205,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.83,06/05/2014,GNRL,198606910
523205,GNRL,"Amgen Inc.",CA,100000000203,12.81,09/09/2015,GNRL,297680034
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.77,06/24/2014,GNRL,149965164
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.69,07/21/2014,GNRL,149510192
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.68,06/06/2014,GNRL,156575500
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.68,08/22/2014,GNRL,156575492
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.65,10/02/2015,GNRL,319572568
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.63,01/23/2015,GNRL,275527060
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.57,12/01/2014,GNRL,150114194
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.55,07/06/2015,GNRL,275527070
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.55,08/24/2015,GNRL,266983580
523205,GNRL,"Lilly USA, LLC",IN,100000000066,12.53,11/24/2015,GNRL,268031264
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.49,09/11/2015,GNRL,275527048
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.46,03/10/2015,GNRL,336920962
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.43,09/15/2014,GNRL,162323358
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.43,02/06/2015,GNRL,319271146
523205,GNRL,"LILLY USA, LLC",IN,100000000066,12.37,07/08/2014,GNRL,137578418
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.37,12/23/2015,GNRL,275527046
523205,GNRL,"Pfizer Inc.",NY,100000000286,12.32,10/28/2015,GNRL,323372302
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.29,09/04/2014,GNRL,148809436
523205,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.16,10/26/2015,GNRL,290485694
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.10,11/25/2014,GNRL,162222806
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.05,05/19/2014,GNRL,156575498
523205,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.05,06/18/2014,GNRL,161619560
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.04,08/14/2015,GNRL,337303900
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.01,11/25/2015,GNRL,254948278
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.98,12/15/2014,GNRL,156575510
523205,GNRL,"Pfizer Inc.",NY,100000000286,11.85,09/24/2015,GNRL,322556106
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.82,11/04/2014,GNRL,188839720
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.70,03/09/2015,GNRL,275527062
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.69,07/28/2014,GNRL,156575502
523205,GNRL,"Amgen Inc.",CA,100000000203,11.68,02/12/2015,GNRL,297680028
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.63,10/21/2014,GNRL,149973872
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.61,06/17/2015,GNRL,256245366
523205,GNRL,"Pfizer Inc.",NY,100000000286,11.58,05/05/2015,GNRL,322864454
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.48,02/02/2015,GNRL,256057301
523205,GNRL,"SANOFI PASTEUR INC.",PA,100000000299,11.46,12/15/2015,GNRL,319282562
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.37,01/23/2015,GNRL,275527058
523205,GNRL,"Lilly USA, LLC",IN,100000000066,11.37,03/26/2015,GNRL,268031260
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.37,05/01/2015,GNRL,319066793
523205,GNRL,"Pfizer Inc.",NY,100000000286,11.31,01/31/2015,GNRL,322715270
523205,GNRL,"Pfizer Inc.",NY,100000000286,11.30,06/27/2014,GNRL,207103720
523205,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.28,05/08/2014,GNRL,198606912
523205,GNRL,"Lilly USA, LLC",IN,100000000066,11.20,10/21/2015,GNRL,268031266
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.19,06/29/2015,GNRL,337240458
523205,GNRL,"Amgen Inc.",CA,100000000203,11.18,10/22/2014,GNRL,138215382
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.15,10/31/2014,GNRL,194423986
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.10,06/26/2015,GNRL,318803756
523205,GNRL,"Supernus Pharmaceuticals, Inc.",MD,100000011150,11.10,08/05/2015,GNRL,335834746
523205,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.08,05/08/2015,GNRL,318838428
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.06,04/13/2015,GNRL,337078588
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.04,08/11/2014,GNRL,194423980
523205,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.81,01/19/2015,GNRL,318838404
523205,GNRL,"Amgen Inc.",CA,100000000203,10.58,08/05/2014,GNRL,138215380
523205,GNRL,"Amgen Inc.",CA,100000000203,10.57,12/10/2014,GNRL,138215384
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.55,10/27/2014,GNRL,156575508
523205,GNRL,"LILLY USA, LLC",IN,100000000066,10.53,10/07/2014,GNRL,137933178
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.48,03/06/2015,GNRL,319634109
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.46,08/04/2014,GNRL,156575504
523205,GNRL,"Pfizer Inc.",NY,100000000286,10.46,05/27/2014,GNRL,206399280
523205,GNRL,"Pfizer Inc.",NY,100000000286,10.45,09/10/2014,GNRL,206173303
523205,GNRL,"Lilly USA, LLC",IN,100000000066,10.30,04/24/2015,GNRL,268031262
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.26,03/02/2015,GNRL,336909516
523205,GNRL,"Lilly USA, LLC",IN,100000000066,10.20,02/23/2015,GNRL,268031258
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.08,11/03/2014,GNRL,156575516
523205,GNRL,"Pfizer Inc.",NY,100000000286,9.96,02/27/2015,GNRL,322335050
523205,GNRL,"Lilly USA, LLC",IN,100000000066,9.85,02/16/2015,GNRL,268031250
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.83,06/02/2014,GNRL,194423975
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.79,05/04/2015,GNRL,275527066
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.72,09/11/2014,GNRL,156575506
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.64,11/15/2014,GNRL,156575518
523205,GNRL,"Pfizer Inc.",NY,100000000286,9.63,01/20/2015,GNRL,322798336
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.60,09/21/2015,GNRL,275527074
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.56,09/21/2015,GNRL,275527072
523205,GNRL,"Pfizer Inc.",NY,100000000286,9.49,08/07/2015,GNRL,323427864
523205,GNRL,"Lilly USA, LLC",IN,100000000066,9.43,04/20/2015,GNRL,268031252
523205,GNRL,"Pfizer Inc.",NY,100000000286,9.39,03/04/2015,GNRL,322838464
523205,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,8.92,11/17/2014,GNRL,150691564
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.97,06/13/2014,GNRL,194423995
523205,GNRL,"Pfizer Inc.",NY,100000000286,7.81,04/10/2015,GNRL,323709859
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.44,08/13/2014,GNRL,194424002
523205,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.90,09/17/2014,GNRL,194424008
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,5.94,06/05/2015,GNRL,318844254
523205,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,5.81,04/08/2015,GNRL,319266208
523205,GNRL,"Pfizer Inc.",NY,100000000286,5.49,07/29/2015,GNRL,323294568
523205,GNRL,"Pfizer Inc.",NY,100000000286,1.76,07/29/2015,GNRL,322504548
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.25,04/22/2015,GNRL,275527052
523205,GNRL,"Astellas Pharma US Inc",IL,100000000137,0.99,08/17/2015,GNRL,294773336
523205,GNRL,"Pfizer Inc.",NY,100000000286,0.71,03/05/2015,GNRL,322886382
523205,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.52,09/29/2014,GNRL,156575514
523205,GNRL,"Pfizer Inc.",NY,100000000286,0.28,01/20/2015,GNRL,323973144
523205,GNRL,"Pfizer Inc.",NY,100000000286,0.26,08/07/2015,GNRL,322424066
523205,GNRL,"Pfizer Inc.",NY,100000000286,0.26,10/28/2015,GNRL,323564844
523205,GNRL,"Pfizer Inc.",NY,100000000286,0.19,07/29/2015,GNRL,322690426
